This review discusses the technical considerations and emerging evidence for using transcatheter heart valves to treat failing surgical bioprostheses (valve-in-valve procedures).
No takes yet. Share an insight, caveat, or question.
May support valve-in-valve TAVI consideration in high-risk patients with failing bioprostheses; leaves open need for prospective trials on durability and outcomes.
Mylotte et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: